Raidium's AI-native radiology viewer adopted by Moffitt Cancer Center
Key Questions
What makes Raidium's radiology viewer unique?
Raidium, a Paris-based French startup, built its radiology viewer from scratch with AI at its core as a foundation model platform.
Where is Raidium's AI-native viewer currently in use?
Moffitt Cancer Center is already using the platform, which reduces reader variability by 3x.
What is the regulatory timeline for Raidium's technology?
FDA clearance is expected by the end of 2026, highlighting European medtech AI momentum.
French startup Raidium built a radiology viewer with AI at its core, reducing reader variability 3x. Already in use at Moffitt Cancer Center. FDA clearance expected end of 2026. Signals European medtech AI momentum and a potential deal sourcing lead. Foundation model viewer approach contrasts with point solutions.
Sources (2)
Updated Jul 20, 2026